what does glp-1 actually do Can one drug it all? Reviewing the expanding clinical universe of agonists Frontiers | GLP−1 receptor agonists
Description
A complete medication review with your prescriber can identify potential interactions
Surging prevalence of type 2 diabetes and growing GLP-1 drug applications are fueling the market growth
The first encouraging human signal came from Athauda and colleagues in 2017
Jain (AstraZeneca, Cambridge, UK) for critical review and comments on the manuscript during preparation
